Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06061653
Other study ID # IIT2023496
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date October 1, 2023
Est. completion date December 31, 2025

Study information

Verified date May 2023
Source First Affiliated Hospital of Zhejiang University
Contact Manli Huang, M.D
Phone 13957162975
Email huangmanli@zju.edu.cn
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Depression is among the most prevalent psychiatric disorders, with an upward trend in its manifestation in younger individuals. In contrast to adult depression, adolescent depression often presents with longer attack durations, higher recurrence rates, chronicity, and elevated disability rates. At present, treatment options for adolescent depression encompass pharmacological, physical, and psychological therapies. However, current evidence suggests that no antidepressant medication is entirely safe for youths, with only fluoxetine and escitalopram being FDA-approved for treating adolescent depression. Given the weight of interpersonal stressors faced by teenagers, the NICE guidelines recommend interpersonal therapy(IPT) as a first-line treatment. A 2020 meta-analysis in the Journal of the American Academy of Child and Adolescent Psychiatry reported that interpersonal therapy exhibited significantly greater improvements in depression symptoms than cognitive behavioral therapy(CBT), although psychotherapeutic effects were modest, achieving a remission rate of 60%. These results underscore the need for further research to enhance interpersonal therapy's effectiveness in treating adolescent depression. High-Definition Transcranial Direct Current Stimulation (HD-tDCS)is a highly secure non-invasive brain stimulation technique that produces sustained effects even after stimulation has discontinued, rendering it particularly valuable for therapeutic interventions. The proposed study aims to augment a single IPT treatment with HD-tDCS stimulation for adolescent depression. By enhancing the excitability of the cerebral cortex, HD-tDCS could potentially enhance IPT's therapeutic efficacy in treating adolescent depression while facilitating further investigation of its underlying neural circuit mechanisms.


Recruitment information / eligibility

Status Recruiting
Enrollment 60
Est. completion date December 31, 2025
Est. primary completion date December 31, 2024
Accepts healthy volunteers No
Gender All
Age group 12 Years to 18 Years
Eligibility Inclusion Criteria: 1. Sign a written informed consent form, willing to participate in the study and accept treatment (patients under 18 years of age need to obtain the consent of their parents or legal guardians); 2. Age between 12 and 18 years; 3. Right-handed; 4. Han ethnicity; 5. Meet the DSM-5 diagnostic criteria for depression; 6. HAMD-24=20; 7. Understand written language and able to complete questionnaires; 8. First-episode depression patients who have never received any treatment or relapse depression patients, have not taken any psychotropic drugs in the past 2 weeks, have not received systematic psychological or physical therapy. Exclusion Criteria: 1. Exclusion criteria for tDCS: (1) Patients with metal implants in the body; those with metal implants such as titanium or magnetic devices (including aneurysm clips); (2) Patients with implanted devices such as cardiac pacemakers, deep brain stimulators (DBS); (3) Patients with intracranial hypertension, skull defects, or tumors; (4) Patients with unstable vital signs such as severe cardiac or somatic diseases; (5) Patients in the acute phase of cerebrovascular diseases; (6) Patients with adverse reactions to electrical stimulation; (7) Patients with pain sensitivity, injury, or inflammation in the stimulation area. 2. Exclusion criteria for MRI; 3. Patients with severe neurological, cardiac, liver, kidney, endocrine, and blood system diseases, or any other condition that may interfere with the study evaluation; 4. Patients with organic mental disorders and mental retardation; 5. Patients with alcohol or drug dependence; 6. Patients with a high risk of suicide.

Study Design


Related Conditions & MeSH terms


Intervention

Combination Product:
IPT plus HD-tDCS
psychotherapy plus device
IPT plus sham HD-tDCS
psychotherapy plus sham device

Locations

Country Name City State
China The First Affiliated Hospital of Zhejiang University Hangzhou Zhejiang

Sponsors (1)

Lead Sponsor Collaborator
First Affiliated Hospital of Zhejiang University

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary 24-item Hamilton Depression Rating Scale Assessment of depressive symptoms. Score<8: normal; >20: mild or moderate depression; >35: severe depression. Baseline
Primary 24-item Hamilton Depression Rating Scale Assessment of depressive symptoms. Score<8: normal; >20: mild or moderate depression; >35: severe depression. 1-month
Primary 24-item Hamilton Depression Rating Scale Assessment of depressive symptoms. Score<8: normal; >20: mild or moderate depression; >35: severe depression. 2-month
Primary 24-item Hamilton Depression Rating Scale Assessment of depressive symptoms. Score<8: normal; >20: mild or moderate depression; >35: severe depression. 3-month
Primary Child Depression Rating Scale-Revised Assessment of depressive symptoms. Score<40: normal; 40~60: mild or moderate depression; >60: severe depression. Baseline
Primary Child Depression Rating Scale-Revised Assessment of depressive symptoms. Score<40: normal; 40~60: mild or moderate depression; >60: severe depression. 1-month
Primary Child Depression Rating Scale-Revised Assessment of depressive symptoms. Score<40: normal; 40~60: mild or moderate depression; >60: severe depression. 2-month
Primary Child Depression Rating Scale-Revised Assessment of depressive symptoms. Score<40: normal; 40~60: mild or moderate depression; >60: severe depression. 3-month
Secondary 17-item Hamilton Anxiety Rating Scale Score<7:No anxiety; Score=7:Possibly anxious; Score=14:Definitely anxious; Score=21:Definitely significantly anxious; Score=29:Possibly severely anxious. Baseline
Secondary 17-item Hamilton Anxiety Rating Scale Score<7:No anxiety; Score=7:Possibly anxious; Score=14:Definitely anxious; Score=21:Definitely significantly anxious; Score=29:Possibly severely anxious. 1-month
Secondary 17-item Hamilton Anxiety Rating Scale Score<7:No anxiety; Score=7:Possibly anxious; Score=14:Definitely anxious; Score=21:Definitely significantly anxious; Score=29:Possibly severely anxious. 2-month
Secondary 17-item Hamilton Anxiety Rating Scale Score<7:No anxiety; Score=7:Possibly anxious; Score=14:Definitely anxious; Score=21:Definitely significantly anxious; Score=29:Possibly severely anxious. 3-month
Secondary Beck Scale for Suicide Ideation Assessment of suicidal ideation. The test taker first completes the initial five questions. If the responses to both the fourth and fifth items are "no," it is considered that there is no suicidal ideation, and the questionnaire concludes. Suicidal risk is evaluated based on items six to nineteen of the scale, which assess the likelihood of actual suicidal behavior among individuals with suicidal ideation. The calculation formula for the total score is [(sum of scores for items six to nineteen) - 9) / 33] * 100, resulting in a score ranging from 0 to 100. A higher score indicates a greater risk of suicide. Baseline
Secondary Beck Scale for Suicide Ideation Assessment of suicidal ideation. The test taker first completes the initial five questions. If the responses to both the fourth and fifth items are "no," it is considered that there is no suicidal ideation, and the questionnaire concludes. Suicidal risk is evaluated based on items six to nineteen of the scale, which assess the likelihood of actual suicidal behavior among individuals with suicidal ideation. The calculation formula for the total score is [(sum of scores for items six to nineteen) - 9) / 33] * 100, resulting in a score ranging from 0 to 100. A higher score indicates a greater risk of suicide. 1-month
Secondary Beck Scale for Suicide Ideation Assessment of suicidal ideation. The test taker first completes the initial five questions. If the responses to both the fourth and fifth items are "no," it is considered that there is no suicidal ideation, and the questionnaire concludes. Suicidal risk is evaluated based on items six to nineteen of the scale, which assess the likelihood of actual suicidal behavior among individuals with suicidal ideation. The calculation formula for the total score is [(sum of scores for items six to nineteen) - 9) / 33] * 100, resulting in a score ranging from 0 to 100. A higher score indicates a greater risk of suicide. 2-month
Secondary Beck Scale for Suicide Ideation Assessment of suicidal ideation. The test taker first completes the initial five questions. If the responses to both the fourth and fifth items are "no," it is considered that there is no suicidal ideation, and the questionnaire concludes. Suicidal risk is evaluated based on items six to nineteen of the scale, which assess the likelihood of actual suicidal behavior among individuals with suicidal ideation. The calculation formula for the total score is [(sum of scores for items six to nineteen) - 9) / 33] * 100, resulting in a score ranging from 0 to 100. A higher score indicates a greater risk of suicide. 3-month
Secondary the Chinese version of the Snaith-Hamilton Pleasure Scale A total of 14 items, each with a score of 1 to 4, will be used to calculate the total score. The higher the score The higher the score, the more severe the pleasure deficit Baseline
Secondary the Chinese version of the Snaith-Hamilton Pleasure Scale A total of 14 items, each with a score of 1 to 4, will be used to calculate the total score. The higher the score The higher the score, the more severe the pleasure deficit 1-month
Secondary the Chinese version of the Snaith-Hamilton Pleasure Scale A total of 14 items, each with a score of 1 to 4, will be used to calculate the total score. The higher the score The higher the score, the more severe the pleasure deficit 2-month
Secondary the Chinese version of the Snaith-Hamilton Pleasure Scale A total of 14 items, each with a score of 1 to 4, will be used to calculate the total score. The higher the score The higher the score, the more severe the pleasure deficit 3-month
Secondary Interpersonal Relationship Scale A score of 0-8 indicates that interpersonal relationship is good, a score of 9-14 indicates that there is a certain degree of interpersonal relationship distress, and a score of 15-28 indicates that interpersonal relationship distress is more serious, that is, the lower the score of the comprehensive diagnostic scale of interpersonal relationship, the better the interpersonal relationship. Baseline
Secondary Interpersonal Relationship Scale A score of 0-8 indicates that interpersonal relationship is good, a score of 9-14 indicates that there is a certain degree of interpersonal relationship distress, and a score of 15-28 indicates that interpersonal relationship distress is more serious, that is, the lower the score of the comprehensive diagnostic scale of interpersonal relationship, the better the interpersonal relationship. 1-month
Secondary Interpersonal Relationship Scale A score of 0-8 indicates that interpersonal relationship is good, a score of 9-14 indicates that there is a certain degree of interpersonal relationship distress, and a score of 15-28 indicates that interpersonal relationship distress is more serious, that is, the lower the score of the comprehensive diagnostic scale of interpersonal relationship, the better the interpersonal relationship. 2-month
Secondary Interpersonal Relationship Scale A score of 0-8 indicates that interpersonal relationship is good, a score of 9-14 indicates that there is a certain degree of interpersonal relationship distress, and a score of 15-28 indicates that interpersonal relationship distress is more serious, that is, the lower the score of the comprehensive diagnostic scale of interpersonal relationship, the better the interpersonal relationship. 3-month
Secondary Emotion Regulation Questionnaire A total of 10 items were scored at 7 points. The higher the score, the higher the frequency of using emotion regulation strategies. Baseline
Secondary Emotion Regulation Questionnaire A total of 10 items were scored at 7 points. The higher the score, the higher the frequency of using emotion regulation strategies. 1-month
Secondary Emotion Regulation Questionnaire A total of 10 items were scored at 7 points. The higher the score, the higher the frequency of using emotion regulation strategies. 2-month
Secondary Emotion Regulation Questionnaire A total of 10 items were scored at 7 points. The higher the score, the higher the frequency of using emotion regulation strategies. 3-month
Secondary Toronto Alexithymia Scale-20 It consists of 3 factors, difficulty identifying feelings (DIF), difficulty describing feelings (DDF), and externally oriented thinking (EOT), which are called F1, F2, and F3 factors, containing 20 items, each scored within a 5-point scale (1: completely disagree to 5: completely agree), 20-100 points, the higher the score, the more pronounced the dysfunction in describing feelings. Baseline
Secondary Toronto Alexithymia Scale-20 It consists of 3 factors, difficulty identifying feelings (DIF), difficulty describing feelings (DDF), and externally oriented thinking (EOT), which are called F1, F2, and F3 factors, containing 20 items, each scored within a 5-point scale (1: completely disagree to 5: completely agree), 20-100 points, the higher the score, the more pronounced the dysfunction in describing feelings. 1-month
Secondary Toronto Alexithymia Scale-20 It consists of 3 factors, difficulty identifying feelings (DIF), difficulty describing feelings (DDF), and externally oriented thinking (EOT), which are called F1, F2, and F3 factors, containing 20 items, each scored within a 5-point scale (1: completely disagree to 5: completely agree), 20-100 points, the higher the score, the more pronounced the dysfunction in describing feelings. 2-month
Secondary Toronto Alexithymia Scale-20 It consists of 3 factors, difficulty identifying feelings (DIF), difficulty describing feelings (DDF), and externally oriented thinking (EOT), which are called F1, F2, and F3 factors, containing 20 items, each scored within a 5-point scale (1: completely disagree to 5: completely agree), 20-100 points, the higher the score, the more pronounced the dysfunction in describing feelings. 3-month
Secondary The Reflective Function Questionnaire for Youths Assesses the degree of agreement or disagreement with narratives about reflective functioning, with higher scores representing higher levels of reflective functioning. Baseline
Secondary The Reflective Function Questionnaire for Youths Assesses the degree of agreement or disagreement with narratives about reflective functioning, with higher scores representing higher levels of reflective functioning. 1-month
Secondary The Reflective Function Questionnaire for Youths Assesses the degree of agreement or disagreement with narratives about reflective functioning, with higher scores representing higher levels of reflective functioning. 2-month
Secondary The Reflective Function Questionnaire for Youths Assesses the degree of agreement or disagreement with narratives about reflective functioning, with higher scores representing higher levels of reflective functioning. 3-month
Secondary Comfort Rating Questionnaire Evaluating adverse reactions of tdcs. Baseline
Secondary Comfort Rating Questionnaire Evaluating adverse reactions of tdcs. 1-month
Secondary Comfort Rating Questionnaire Evaluating adverse reactions of tdcs. 2-month
Secondary Comfort Rating Questionnaire Evaluating adverse reactions of tdcs. 3-month
Secondary IL-6 level Detection of serum IL-6 levels using flow cytometry. The normal value is 0-5.30 pg/ml. There is a goodcorrelation between depression and elevated serum IL-6 levels. Baseline
Secondary IL-6 level Detection of serum IL-6 levels using flow cytometry. The normal value is 0-5.30 pg/ml. There is a goodcorrelation between depression and elevated serum IL-6 levels. 2-month
Secondary MRI data Reflecting brain structure and function Baseline
Secondary MRI data Reflecting brain structure and function 2-month
Secondary EEG data Reflecting brain function. It will be used for analysing Left-right asymmetry of forehead Alpha wave energy,mapping the brainnetworks. Baseline
Secondary EEG data Reflecting brain function. It will be used for analysing Left-right asymmetry of forehead Alpha wave energy,mapping the brainnetworks. 2-month
Secondary TMS-evoked potentials(TEPs) Reflecting cortical excitability. N15, P30, N45, P55, N100, P180 and N280 components were evoked during single-pulse TMS stimulation of motor cortex (M1). Early components of TEPs (N15-P30) reflect cortical excitatory activity, while other components (N45-N100) are associated with cortical inhibitory activity. Baseline
Secondary TMS-evoked potentials(TEPs) Reflecting cortical excitability. N15, P30, N45, P55, N100, P180 and N280 components were evoked during single-pulse TMS stimulation of motor cortex (M1). Early components of TEPs (N15-P30) reflect cortical excitatory activity, while other components (N45-N100) are associated with cortical inhibitory activity. 2-month
Secondary Thinc-integrated Tools(THINC-it) THINC-it(https://progress.im/en/)is the first tool to assess cognitive functioning in MDD using both subjective and objective tests and is available as a free download for use on tablets, smartphones or computers. The tool's four objective test sections use recognized cognitive paradigms to assess subjects' performance in the key cognitive domains of attention, working memory, and executive function. The Choice Reaction Time (CRT) focuses on attention and executive function, the 1-Back Memory Task (1-Back) examines memory, attention/concentration, and executive function, the Digit Symbol Substitution Test (DSST) examines processing speed, attention, and executive function, and the Test of Connectivity B (TMT-B) assesses executive function. The 5-item Cognitive Impairment Questionnaire (PDQ?5?D) is the subjective component of the instrument and can be used to assess patients' performance in attention/concentration, planning/organization, retrospection, and prospective memory. Baseline
Secondary Thinc-integrated Tools(THINC-it) THINC-it(https://progress.im/en/)is the first tool to assess cognitive functioning in MDD using both subjective and objective tests and is available as a free download for use on tablets, smartphones or computers. The tool's four objective test sections use recognized cognitive paradigms to assess subjects' performance in the key cognitive domains of attention, working memory, and executive function. The Choice Reaction Time (CRT) focuses on attention and executive function, the 1-Back Memory Task (1-Back) examines memory, attention/concentration, and executive function, the Digit Symbol Substitution Test (DSST) examines processing speed, attention, and executive function, and the Test of Connectivity B (TMT-B) assesses executive function. The 5-item Cognitive Impairment Questionnaire (PDQ?5?D) is the subjective component of the instrument and can be used to assess patients' performance in attention/concentration, planning/organization, retrospection, and prospective memory. 2-month
Secondary Perceptual judgment test Assess subjects' perception of interpersonal information. Baseline
Secondary Perceptual judgment test Assess subjects' perception of interpersonal information. 2-month
Secondary Distance memory test Assessment of Working memory. Baseline
Secondary Distance memory test Assessment of Working memory. 2-month
Secondary ERP experiment The participants are instructed to watch the animations,while EEG data is recorded. Event-related Mu-wave will be used for evaluating social interaction ability. Baseline
Secondary ERP experiment The participants are instructed to watch the animations,while EEG data is recorded. Event-related Mu-wave will be used for evaluating social interaction ability. 2-month
See also
  Status Clinical Trial Phase
Completed NCT01316926 - Paxil CR Bioequivalence Study Brazil Phase 1
Recruiting NCT06187454 - Transcranial Direct Current Stimulation for Depression N/A
Completed NCT04469322 - Pharmacogenetic Implementation Trial in Veterans With Treatment Refractory Depression N/A
Recruiting NCT05768126 - Prediction of ECT Treatment Response and Reduction of Cognitive Side-effects Using EEG and Rivastigmine Phase 4
Completed NCT03219879 - Telephone-administered Relapse Prevention for Depression N/A
Recruiting NCT06038721 - Unified Protocol: Community Connections N/A
Completed NCT03043560 - Study to Treat Major Depressive Disorder With a New Medication Phase 2
Completed NCT04091139 - Research of Unified Protocol for the Treatment of Common Mental Disorders in Adolescents in Hong Kong Phase 2/Phase 3
Completed NCT00069459 - Seasonal Affective Depression (SAD) Study Phase 1
Recruiting NCT05503966 - Combining Antidepressants and Attention Bias Modification in Depression N/A
Recruiting NCT03001245 - Interpersonal Counseling (IPC) for Treatment of Depression in Adolescents N/A
Completed NCT02939560 - TMS for Adults With Autism and Depression N/A
Completed NCT02542891 - European Comparative Effectiveness Research on Internet-based Depression Treatment N/A
Completed NCT02452892 - Low Field Magnetic Stimulation (LFMS) in Subjects With Treatment-Resistant Depression (TRD) N/A
Completed NCT02224508 - Evaluation of a Health Plan Initiative to Mitigate Chronic Opioid Therapy Risks N/A
Withdrawn NCT02238730 - Ultrabrief Right Unilateral and Brief Pulse Bitemporal Electroconvulsive Therapy N/A
Completed NCT02306551 - Well Being And Resilience: Mechanisms of Transmission of Health and Risk
Completed NCT01597661 - Bupropion & Cardio Birth Defect (Slone) N/A
Completed NCT01407575 - Buprenorphine for Treatment Resistant Depression Phase 3
Completed NCT01093053 - Mind-Body Skills Groups for the Treatment of War Zone Stress in Military and Veteran Populations N/A